Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 4, 2010
A novel finding of a low-molecular-weight compound, SMTP-7, having thrombolytic and anti-inflammatory effects in cerebral infarction of miceKeita Shibata, Terumasa Hashimoto, Koji Nobe, et al.
Biological & Pharmaceutical Bulletin|January 7, 2026
SMTP-44D Exerts Renoprotective Effects against Diabetic Nephropathy via Its Anti-inflammatory and Antioxidant ActionTaiki Awane, Hayato Sasaki, Keita Shibata, et al.
Journal of Pharmacological Sciences|July 26, 2025
SMTP-44D prevents negative symptoms of diabetic neuropathy by inhibiting sciatic nerve apoptosisAyaka Aoki, Keita Shibata, Ryosuke Shinouchi, et al.
Journal of Diabetes and Its Complications|May 3, 2025
Antioxidant and anti-inflammatory effects of SMTP-44D in a streptozotocin-induced diabetic neuropathy mouse modelRyosuke Shinouchi, Keita Shibata, Taiju Nagatsuka, et al.
Journal of Pharmacological Sciences|August 27, 2025
Therapeutic potential of SMTP-27 in attenuating diabetic nephropathy with anti-inflammatory activityKeita Shibata, Taiki Awane, Takashi Takaki, et al.
Journal of Pharmacological Sciences|May 3, 2014
Altered gene expression in an embolic stroke model after thrombolysis with tissue plasminogen activator and Stachybotrys microspora triprenyl phenol-7Terumasa Hashimoto, Keita Shibata, Hisayuki Ohata, et al.
Pharmacology Research & Perspectives|November 20, 2020
SMTP-44D improves diabetic neuropathy symptoms in mice through its antioxidant and anti-inflammatory activitiesRyosuke Shinouchi, Keita Shibata, Terumasa Hashimoto, et al.
Pageof 4